Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 4, Pages 561-571
Publisher
Informa Healthcare
Online
2014-03-04
DOI
10.1517/13543784.2014.892581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
- (2013) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Emerging treatments for hepatitis C
- (2013) Robert Flisiak et al. EXPERT OPINION ON EMERGING DRUGS
- Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature
- (2013) Ferdinando Fusco et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection
- (2013) Edward J. Gane et al. GASTROENTEROLOGY
- A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C
- (2013) Ivan Gentile et al. Hepatitis Monthly
- HCV therapeutics: New agents
- (2013) HEPATOLOGY
- Association of tattooing and hepatitis C virus infection: A multicenter case-control study
- (2013) Kerrilynn Carney et al. HEPATOLOGY
- Age and Gender Distribution of Hepatitis C Virus Genotypes in the Metropolitan Area of Naples
- (2013) Arnolfo Petruzziello et al. INTERVIROLOGY
- Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells
- (2013) Nicola Coppola et al. JOURNAL OF CLINICAL VIROLOGY
- 14 ALL-ORAL SOFOSBUVIR-BASED 12-WEEK REGIMENS FOR THE TREATMENT OF CHRONIC HCV INFECTION: THE ELECTRON STUDY
- (2013) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- 13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION
- (2013) G.T. Everson et al. JOURNAL OF HEPATOLOGY
- 64 GS-5885 + GS-9451 + PEGINTERFERON AND RIBAVIRIN (PR) FOR SIX OR TWELVE WEEKS ACHIEVES HIGH SVR12 RATES IN TREATMENT-NAÏVE GENOTYPE 1 IL28B CC PATIENTS
- (2013) A. Thompson et al. JOURNAL OF HEPATOLOGY
- Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
- (2013) Christophe Hézode et al. JOURNAL OF HEPATOLOGY
- NS5A inhibitors in the treatment of hepatitis C
- (2013) Jean-Michel Pawlotsky JOURNAL OF HEPATOLOGY
- Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
- (2013) R. Zampino et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained virological response: A milestone in the treatment of chronic hepatitis C
- (2013) Filomena Morisco WORLD JOURNAL OF GASTROENTEROLOGY
- Profile of alisporivir and its potential in the treatment of hepatitis C
- (2013) Philippe Gallay et al. Drug Design Development and Therapy
- Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
- (2012) M. Fenaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural history of acute and chronic hepatitis C
- (2012) Benjamin Maasoumy et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
- (2012) Nicola Coppola et al. BMC INFECTIOUS DISEASES
- Current prospects for interferon-free treatment of hepatitis C in 2012
- (2012) Catherine AM Stedman JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 1215 PERSISTENCE OF NS5A GS-5885 DRUG RESISTANCE MUTATIONS FOLLOWING 3 DAYS OF MONOTHERAPY IN GENOTYPE-1 HCV PATIENTS IS DEPENDENT ON THE HCV SUBTYPE AND SPECIFIC MUTATION
- (2012) K.A. Wong et al. JOURNAL OF HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- 1172 ANTIVIRAL ACTIVITY AND RESISTANCE PROFILE OF THE NOVEL HCV NS5A INHIBITOR GS-5885
- (2012) G. Cheng et al. JOURNAL OF HEPATOLOGY
- A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C
- (2012) Eric J. Lawitz et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients
- (2012) Assy Nimer WORLD JOURNAL OF GASTROENTEROLOGY
- Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy
- (2011) Nicola Coppola et al. DIGESTIVE AND LIVER DISEASE
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
- (2011) Saif Abu-Mouch WORLD JOURNAL OF GASTROENTEROLOGY
- Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
- (2010) Ivan Gentile et al. JOURNAL OF HEPATOLOGY
- Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
- (2010) Christian Markus Lange et al. JOURNAL OF HEPATOLOGY
- Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2009) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
- (2009) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index
- (2009) Nicola Coppola et al. JOURNAL OF CLINICAL VIROLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now